Quidel’s Lyra® Direct SARS-CoV-2 Assay Submitted for Emergency Use Authorization for Molecular Detection of COVID-19, Without Extraction Step
QuidelOrtho Corporation (QDEL)
Last quidelortho corporation earnings: 2/12 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.quidel.com
Company Research
Source: Business Wire
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has applied for an Emergency Use Authorization (EUA) for the Lyra® Direct SARS-CoV-2 Assay from the Food and Drug Administration (FDA) to allow direct sample processing. The assay will be run on the same six different instruments as the Lyra® SARS-CoV-2 Assay.Lyra® Direct Removes RNA Extraction Processing Step, Removes Supply Bottleneck Under the new EUA, the Lyra® Direct SARS-CoV-2 Assay no longer requires an upfront sample extraction. The Lyra® Direct SARS-CoV-2 Assay uses a reformulated buffer that replaces the extraction step with a simple 10-minute heat step, saving approximately 50 minutes in processing time. The assay retains its versatility in that it is still capable of running on any of six thermocyclers (Applied Biosystems 7500 Standard®, Applied Biosystems
Show less
Read more
Impact Snapshot
Event Time:
QDEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QDEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QDEL alerts
High impacting QuidelOrtho Corporation news events
Weekly update
A roundup of the hottest topics
QDEL
News
- QuidelOrtho Looks Mispriced If 2026's FCF Turnaround Materializes [Seeking Alpha]Seeking Alpha
- QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance [TheStreet.com]TheStreet.com
- QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 GuidancePR Newswire
- QuidelOrtho (QDEL) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=QDEL&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "buy" to "hMarketBeat
- QuidelOrtho (QDEL) Is Down 7.6% After Proposed US Health Funding Cuts Raise Policy Uncertainty [Yahoo! Finance]Yahoo! Finance
QDEL
Earnings
- 2/11/26 - Beat
QDEL
Sec Filings
- 4/15/26 - Form 8-K
- 4/8/26 - Form SCHEDULE
- 3/31/26 - Form 3
- QDEL's page on the SEC website